OracleBio’s Chief Scientific Officer, Lorcan Sherry, recently joined Aleksandra Zuraw on the Digital Pathology Place podcast.
During the podcast, Aleks and Lorcan have a conversation about the history of OracleBio and the company’s journey to GCP Image Analysis. Listen to the episode to hear Aleks and Lorcan discuss:
- Lorcan’s background and the origins of OracleBio
- OracleBio’s use of image analysis software platforms
- Processes for assuring image analysis data is of a high quality
- Pathologist input throughout the image analysis workflow
- How the company innovates
- and more!
Reasons to Work With OracleBio:
Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
Latest technologies – We continually invest time and money into the latest software and techniques so you don’t need to
More from OracleBio:
Using Deep Learning to address Staining Variance across Multiplex IF images
Multiplex IF assays are highly valuable in generating data that enables a deeper understanding of cell phenotypes, their functional status, and spatial relationships within tissues across different diseases or therapeutic interventions. However, the staining of...
Appraise, Action, Adapt & Adopt – Our continuous improvements in GCP
Earlier this year, we announced that OracleBio is now conducting quantitative image analysis on clinical trial samples in accordance with Good Clinical Practices (GCP). Having recognised these standards, it is important to ensure that this high-level quality is...
Still at the Cutting Edge: Microtomy and Digital Pathology
In 2012, my friend and colleague Dr. Gabriele Kohnen salvaged three identical old microtomes from a skip (dumpster for our friends in the US!). After storing them in her garage for a decade, she gave them to me. I guessed they might date from the 1930s, but...
Find out more about our Software Capabilities
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more

